The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virus
Abstract
Hepatitis A virus (HAV) is an unusual picornavirus with two types of extracellular virions: nonenveloped particles (nHAV) shed in feces and quasi-enveloped particles (eHAV) circulating in blood. Both enter cells by clathrin-dependent endocytic pathways merging in late endolysosomes with capsid binding to ganglioside receptors. Phosphatidylserine receptors facilitate eHAV endocytosis, but no protein receptor has been identified for nHAV. Here, we show low-density lipoprotein receptor (LDLR) is such a receptor. LDLR knockout did not alter viral attachment to cells, but restricted cellular uptake of nHAV (not eHAV). Soluble LDLR ectodomain blocked nHAV entry, as did antibody to LDLR. Recombinant LDLR-related protein-associated protein 1, a pan-LDLR family chaperone, also inhibited nHAV entry, including residual entry into knockout cells, suggesting other LDLR family members may similarly facilitate endocytosis. Reconstituting full-length LDLR expression restored nHAV entry in knockout cells, whereas LDLR mutants lacking LA repeats 4 to 7 or the EGF-like/propeller domain did not. ELISAs confirmed LDLR binds nHAV, optimally above pH7, without destabilizing the capsid. A 1.7Å resolution cryoelectron microscopy (cryo-EM) structure revealed LDLR interacts with VP1 at the fivefold vertex of the capsid. Extreme blurring of the LDLR density prevented detailed identification of LDLR interactions, and suggested binding does not follow particle symmetry, being either flexible or to multiple LDLR regions. Additional cryo-EM studies show ganglioside GD1a binds to a similar region of the capsid. Collectively, these data reveal the LDLR to be an important entry factor, shuttling nHAV from the extracellular environment to endolysosomes where it is likely released at low pH to bind gangliosides.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (13)
Tomoyuki Shiota
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill
Yuguang Zhao
Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford
Itoe Shiota
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill
Helen M. E. Duyvesteyn
Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford
Manami Yamaoka
Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe
Anshuman Das
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill
Maryna Kapustina
Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill
Pranav Shah
Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford
Masamichi Muramatsu
Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe
Xiangxi Wang
State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences
Elizabeth E. Fry
Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford
David I. Stuart
Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford
Stanley M. Lemon
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill